|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.45 USD | +2.84% |
|
-7.94% | -21.20% |
| May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
| May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Biodesix, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 14.82 million compared to USD 9.06 million a year ago. Net loss was USD 13.61 million compared to USD 18.7 million a year ago.
Basic loss per share from continuing operations was USD 0.14 compared to USD 0.24 a year ago. Diluted loss per share from continuing operations was USD 0.14 compared to USD 0.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.20% | 162M | |
| -23.07% | 8.1B | |
| +68.36% | 4.26B | |
| +1.88% | 2.57B | |
| -8.06% | 2.49B | |
| -41.95% | 2.39B | |
| -11.99% | 1.77B | |
| -21.18% | 1.53B | |
| +17.44% | 1.2B | |
| -43.89% | 1.18B |
BIODESIX, INC. 
